VYNE Therapeutics (VYNE) Q3 2023 Earnings

13NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-3.24
-2.65
-2.07
-1.48

Details

Expected EPS
-1.97
Actual EPS
-1.75
Surprise EPS
0.22
Surprise Percent
+11.17%

Description

VYNE Therapeutics (VYNE) has reported earnings of -1.75 per share for Q3 2023.

0 Comments

Share your thoughts